Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Permeabilization Market

Cell Permeabilization Market Trends

  • Report ID: GMI9701
  • Published Date: May 2024
  • Report Format: PDF

Cell Permeabilization Market Trends

The field of regenerative medicine has witnessed remarkable advancements in cell-based therapies, offering promising solutions for treating a wide range of diseases and medical conditions. From stem cell therapy to CAR-T cell immunotherapy, these innovative approaches harness the power of living cells to restore tissue function, modulate immune responses, and combat disease progression. Central to the success of many cell-based therapies is the ability to efficiently deliver therapeutic agents into target cells while maintaining cell viability and functionality.
 

  • Cell permeabilization techniques enable the efficient delivery of therapeutic agents into cells. With advancements in cell-based therapies such as stem cell therapy or CAR-T cell therapy, cell permeabilization methods can be employed to enhance the uptake of therapeutic molecules, including small molecules, nucleic acids, or proteins, into target cells for improved therapeutic efficacy.
     
  • It facilitates the delivery of gene-editing tools such as CRISPR-Cas9, into cells for precise genome modification. In cell-based therapies involving gene editing such as ex vivo gene therapy or genome engineering of stem cells, optimized cell permeabilization techniques ensure effective delivery of gene-editing components to target cells, enabling precise genetic modifications and therapeutic outcomes.
     
  • Further, cell permeabilization enables the controlled release of therapeutic payloads from encapsulated cells or cell-derived vesicles. In cell-based drug delivery systems, such as cell-mimetic nanoparticles or engineered cell vesicles, permeabilization techniques allow for precise control over the timing and location of drug release within target tissues, minimizing off-target effects and improving therapeutic outcomes. Thereby, escalating the growth of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cell permeabilization market size was valued at USD 1.2 billion in 2023 and is estimated to grow at 4.3% CAGR from 2024 to 2032, driven by usage for various applications, including immunofluorescence staining and in situ hybridization.

The organic solvent segment of the market will reach USD 345.4 million by 2032, as they are readily available and commonly used in laboratory settings, making them easily accessible for cell permeabilization experiments.

U.S. cell permeabilization market size was USD 499.2 million in 2023, and is set to continue to grow through 2032, driven by the increasing prevalence of chronic diseases, such as cancer.

Agilent Technologies, Inc, Boster Biological Technology, Cell Signaling Technology, Inc, Cyanagen, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina, Inc, International Stem Cell Corporation, and IQ Products among others.

Cell Permeabilization Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 222
  • Countries covered: 23
  • Pages: 160
 Download Free Sample